Skip to content

Photobiomodulation and Vestibular Rehabilitation in women

Photobiomodulation Combined with Vestibular Rehabilitation in women with Unilateral Peripheral Hypofunction: a randomized, blinded clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4z9mt9h
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertigo

Interventions

Eligible participants will be randomly allocated using simple randomization into three experimental groups, with ten participants in each group. Randomization will be performed by an independent resea

Sponsors

Faculdade de Odontologia de Bauru da Universidade de São Paulo
Lead Sponsor
IAVE – Instituo da Audição, Voz e Equilíbrio
Collaborator

Eligibility

Sex/Gender
Female
Age
30 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women; aged between thirty and forty years; bilateral hearing thresholds within normal limits according to pure tone and speech audiological assessment; speech language pathology diagnosis of unilateral peripheral vestibular hypofunction identified by the video head impulse test vHIT specifically characterized by alterations in vestibulo ocular gain at high head impulse frequencies; presence of intact middle ear and auditory pathways up to the brainstem confirmed by acoustic immittance measures and stapedial reflex testing; absence of a history of diseases related to neurological disorders and cognitive complaints that would prevent the performance of examinations or questionnaires

Exclusion criteria

Exclusion criteria: Presence of unilateral or bilateral hearing loss, regardless of type; presence of bilateral vestibulopathy; presence of central vestibulopathy; history of restricted ocular movement, including vergence disorders, strabismus, or high-degree refractive errors; alterations related to right ocular globe movement, right eyelid ptosis, as well as scars that impair detection of the right pupil; limitations in cervical mobility; presence of metabolic disorders or uncontrolled blood pressure; significant hormonal alterations, such as thyroid disorders, use of hormone replacement therapy, or use of contraceptives that may interfere with vestibular function or emotional state; clinical diagnosis of depression based on medical evaluation or prior report with use of antidepressant medication; functional or structural alterations of the middle ear identified through acoustic immittance assessment or otologic clinical examination

Design outcomes

Primary

MeasureTime frame
It is expected to observe improvement in symptoms related to vestibular dysfunction in women with unilateral peripheral vestibular hypofunction undergoing vestibular rehabilitation with or without photobiomodulation, verified through clinical and functional vestibular assessment instruments applied before and after the intervention, based on comparison of scores obtained at the pre intervention period after the fifth session and after the tenth session, considering a clinically significant reduction in vestibular symptoms and improvement in functional performance

Secondary

MeasureTime frame
It is expected to observe additional improvement in functional performance and postural balance in participants undergoing vestibular rehabilitation associated with active photobiomodulation compared to control and placebo groups, verified through complementary clinical measures of balance and postural stability applied before and after the intervention, based on identification of differences in functional scores between groups at the end of the treatment protocol

Countries

Brazil

Contacts

Public ContactKátia Alvarenga

Faculdade de Odontologia de Bauru da Universidade de São Paulo

katialv@fob.usp.br+55(14)32358000

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 7, 2026